| SteriPort bottle capacity | 11.6 crore bottles |
|---|
BSE filing, NSE: AMANTA. Summary written from the filing by ALFA Finder's alert engine.
Amanta Healthcare Ltd: key numbers
- Share price
- ₹172.48
- Market cap
- ₹669.7 Cr
- Revenue (annual)
- ₹287.7 Cr
- Net profit (annual)
- ₹14.88 Cr
- P/E (TTM)
- 36.5×Sector 41.3×
- Promoter holding
- 63.80%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amanta Healthcare Ltd
All →Amanta Healthcare Investor Presentation: Key Takeaways
Q2FY27 revenue ₹83.1 Cr (+17.3% YoY), EBITDA ₹17.95 Cr (21.6% margin), PAT ₹4.86 Cr. H1 revenue ₹151.9 Cr, PAT ₹8.2 Cr. SteriPort Line 3 commissioned September 2026.
- Call
- Guides 20% growth
Amanta Healthcare Q2 FY27 Results: Net Profit ₹4.9 Cr, Up 308.3% YoY
Amanta Healthcare Ltd reported revenue from operations of ₹83.1 Cr (+17.2% YoY) and net profit of ₹4.9 Cr (+308.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹4.9 Cr · +308.3% YoY
Amanta Healthcare Other Announcement
Amanta Healthcare's quarterly shareholding pattern as at 30 Sep 2026 shows promoter and promoter group holding at 31.33%. The filing notes a gift-based promoter group addition, but is a routine periodic disclosure.
Amanta Healthcare Management Change
Amanta Healthcare's COO Shri Anil Rathi resigned effective October 29, 2026. The departure is disclosed under Regulation 30 of the SEBI Listing Regulations.
Amanta Healthcare Board Meeting Date
Amanta Healthcare intimated a Board Meeting scheduled for 3 Nov 2026 to approve Q1 & H1 FY27 unaudited results. Trading window reopens on 6 Nov 2026.
Amanta Healthcare Other Announcement
Amanta Healthcare Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Other results update announcements
All →Sundaram-Clayton Results Update
Sundaram-Clayton's Q2 FY27 standalone revenue rose 37% to ₹631.9 Cr; PAT jumped 96% to ₹39.5 Cr. H1 income grew 28% to ₹1,159.8 Cr on strong automotive demand.
Ester Industries Results Update
Ester Industries posted Q2FY27 revenue of ₹449 Cr (up 26%) and EBITDA of ₹45 Cr (up 160% Y-o-Y). PAT swung to ₹7.8 Cr profit from a ₹15.8 Cr loss.
HMA Agro Industries Results Update
HMA Agro posted Q2 FY27 revenue of ₹2,779 Cr and PAT of ₹105 Cr. H1 FY27 revenue stood at ₹4,890 Cr with PAT of ₹155 Cr.
Cera Sanitaryware Results Update
Cera Sanitaryware released its Q2 FY27 investor communication highlighting revenue of ₹603 crore, EBITDA of ₹84 crore, and PAT of ₹56 crore. The board approved unaudited results for the quarter and half year ended September 30, 2026.
Zydus Lifesciences Results Update
Zydus Lifesciences reported Q2 FY27 revenue of Rs. 79,096 mn, up 29% y-o-y. H1 net profit was Rs. 18,859 mn, down 31%.
Vishal Fabrics Results Update
Vishal Fabrics reported Q2 FY27 PAT of ₹10.6 crore, up 21% YoY, and EBITDA margin of 7.9%. The board also appointed Mr. Rajav as CEO.